Clinical Trial Update: Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on tigecycline for severe sepsis and septic shock (Phase 2/Phase 3) with abdominal infection as a condition; the current status is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Abdominal Infection | Phase 2, Phase 3 | Status: UNKNOWN